1
Adjuvant trastuzumab trials NSABP B-31 NCCTG 9831 H…x 52 H…x 52 H…x 52 H…x 52 H…x 52 BCIRG 006 H…x 1 years H…x 2 years No therapy Standard ChemoRx HERA

Adjuvant trastuzumab trials

Embed Size (px)

DESCRIPTION

Adjuvant trastuzumab trials. NSABP B-31. BCIRG 006. H…x 52. H…x 52. H…x 52. NCCTG 9831. HERA. No therapy. Standard ChemoRx. H…x 52. H…x 1 years. H…x 52. H…x 2 years. - PowerPoint PPT Presentation

Citation preview

Page 1: Adjuvant trastuzumab trials

Adjuvant trastuzumab trials

NSABP B-31

NCCTG 9831

H…x 52

H…x 52

H…x 52

H…x 52

H…x 52

BCIRG 006

H…x 1 years

H…x 2 years

No therapy

StandardChemoRx

HERA

Adjuvant! Online ! Online - NKIresearch.nki.nl/amaros/Symposium 2009/Adjuvant Online.pdf · 2009. 11. 13. · Adjuvant Adjuvant & MammaPrint MammaPrint (70-genen profiel) • Pooled

Adjuvant! Online ! Online - NKIresearch.nki.nl/amaros/Symposium 2009/Adjuvant Online.pdf · 2009. 11. 13. · Adjuvant Adjuvant & MammaPrint MammaPrint (70-genen profiel) • Pooled

Documents
FBCG A randomized phase III study of adjuvant trastuzumab ......an employee of 4Pharma Ltd. PKL has a consulting role with Sanofi, Pfizer, Roche, and Bristol-Myers Squibb, and has

FBCG A randomized phase III study of adjuvant trastuzumab ......an employee of 4Pharma Ltd. PKL has a consulting role with Sanofi, Pfizer, Roche, and Bristol-Myers Squibb, and has

Documents
Adding Trastuzumab to Adjuvant Chemotherapy in Breast Cancer

Adding Trastuzumab to Adjuvant Chemotherapy in Breast Cancer

Healthcare
PHARE* Trial results of subset analysis comparing 6 to 12 … · PHARE* Trial results of subset analysis comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer Protocol

PHARE* Trial results of subset analysis comparing 6 to 12 … · PHARE* Trial results of subset analysis comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer Protocol

Documents
jurnal trastuzumab ca mammae

jurnal trastuzumab ca mammae

Education
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall

The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall

Documents
TUCATINIB, TRASTUZUMAB, AND CAPECITABINE

TUCATINIB, TRASTUZUMAB, AND CAPECITABINE

Documents
PERSEPHONE: 6 versus 12 months of adjuvant trastuzumab in ... · OS: Pre-defined subgroup analysis Interaction between 2 groups c2 1=5.5; p=0.02 Heterogeneity between 4 groups c2

PERSEPHONE: 6 versus 12 months of adjuvant trastuzumab in ... · OS: Pre-defined subgroup analysis Interaction between 2 groups c2 1=5.5; p=0.02 Heterogeneity between 4 groups c2

Documents
AMS-01 STUBBLE TRIALS 2015 · AMS-01 STUBBLE TRIALS 2015 Independent herbicide + adjuvant trials Replicated plots By Agricultural Academy Institute of Agriculture Karnobat, Bulgaria

AMS-01 STUBBLE TRIALS 2015 · AMS-01 STUBBLE TRIALS 2015 Independent herbicide + adjuvant trials Replicated plots By Agricultural Academy Institute of Agriculture Karnobat, Bulgaria

Documents
HER2 and adjuvant trastuzumab Soonmyung Paik, MD NSABP Foundation

HER2 and adjuvant trastuzumab Soonmyung Paik, MD NSABP Foundation

Documents
Novel Therapies for Triple Negative, HER2+ and ER+ Breast ......HER2+ Breast Cancer Following Adjuvant Trastuzumab: Risk of Locoregional or Distant Recurrence Approximately 20% of

Novel Therapies for Triple Negative, HER2+ and ER+ Breast ......HER2+ Breast Cancer Following Adjuvant Trastuzumab: Risk of Locoregional or Distant Recurrence Approximately 20% of

Documents
Neo-adjuvant and adjuvant treatment for HER-2+ breast cancer...breast cancer FEC q3w x 3 Trastuzumab q3w cycles 5-17 FEC q3 x 3 Trastuzumab q3w cycles 5-17 Gianni L, et al. Cancer

Neo-adjuvant and adjuvant treatment for HER-2+ breast cancer...breast cancer FEC q3w x 3 Trastuzumab q3w cycles 5-17 FEC q3 x 3 Trastuzumab q3w cycles 5-17 Gianni L, et al. Cancer

Documents
HERCEPTIN (trastuzumab) Label

HERCEPTIN (trastuzumab) Label

Documents
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive

Documents
Adjuvant Trastuzumab in early breast cancer22medinfo2.psu.ac.th/surgery/Collective review/2552/6... · 1 Adjuvant Trastuzumab in early breast cancer . .. ˘ ˇ ˆ ˙˝ ˛˚˜ ! ˛

Adjuvant Trastuzumab in early breast cancer22medinfo2.psu.ac.th/surgery/Collective review/2552/6... · 1 Adjuvant Trastuzumab in early breast cancer . .. ˘ ˇ ˆ ˙˝ ˛˚˜ ! ˛

Documents
Herceptin (trastuzumab) Data Sheet

Herceptin (trastuzumab) Data Sheet

Documents
Breast Cancer: HER2+ & ER+ - Hope Health Centerhopehealthreseda.com/Articles/Friday Hurvitz Breast Cancer - HER2 E… · Overall Survival Early Breast Cancer Impact of adjuvant trastuzumab

Breast Cancer: HER2+ & ER+ - Hope Health Centerhopehealthreseda.com/Articles/Friday Hurvitz Breast Cancer - HER2 E… · Overall Survival Early Breast Cancer Impact of adjuvant trastuzumab

Documents
Research Paper YAP increases response to Trastuzumab in ...Research Paper YAP increases response to Trastuzumab in ... ... trastuzumab

Research Paper YAP increases response to Trastuzumab in ...Research Paper YAP increases response to Trastuzumab in ... ... trastuzumab

Documents
UnitedHealthcare Cancer Therapy Pathways Program Regimens · Gianni, L., et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer

UnitedHealthcare Cancer Therapy Pathways Program Regimens · Gianni, L., et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer

Documents
Ten years of using adjuvant trastuzumab in breast cancer ... · 354 Adjuvant trastuzumab in breast cancer in Serbia JBUON 2018; 23(2): 354 clinical outcomes. Adjuvant trastuzumab

Ten years of using adjuvant trastuzumab in breast cancer ... · 354 Adjuvant trastuzumab in breast cancer in Serbia JBUON 2018; 23(2): 354 clinical outcomes. Adjuvant trastuzumab

Documents
Kadcyla, INN-trastuzumab emtansine · T-DM1 Trastuzumab emtansine, Kadcyla TNBC triple-negative breast cancer TTZ Trastuzumab ypTN Post-neoadjuvant treatment pathological stage of

Kadcyla, INN-trastuzumab emtansine · T-DM1 Trastuzumab emtansine, Kadcyla TNBC triple-negative breast cancer TTZ Trastuzumab ypTN Post-neoadjuvant treatment pathological stage of

Documents
Current Patterns of Care in Breast Cancer: Use of Adjuvant Trastuzumab

Current Patterns of Care in Breast Cancer: Use of Adjuvant Trastuzumab

Documents
for (trastuzumab and hyaluronidase-oysk) - Genentech · 2020. 7. 16. · HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) is indicated for adjuvant treatment of adults with

for (trastuzumab and hyaluronidase-oysk) - Genentech · 2020. 7. 16. · HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) is indicated for adjuvant treatment of adults with

Documents
Personalized adjuvant therapy based on clinica trials in breast …gbcc.kr/GBCC2017_upload/PFile_02_15_SP6 2_Martin Piccart.pdf · 2020-04-07 · Trials ExploringShorterDurations

Personalized adjuvant therapy based on clinica trials in breast …gbcc.kr/GBCC2017_upload/PFile_02_15_SP6 2_Martin Piccart.pdf · 2020-04-07 · Trials ExploringShorterDurations

Documents
Prevention of Cardiac Dysfunction During Adjuvant …/media/Clinical/PDF-Files/Approved-PDFs/2015...• Anthracycline-containing chemotherapy and trastuzumab prolong survival in patients

Prevention of Cardiac Dysfunction During Adjuvant …/media/Clinical/PDF-Files/Approved-PDFs/2015...• Anthracycline-containing chemotherapy and trastuzumab prolong survival in patients

Documents
AusPAR Attachment 1. Product Information for Trastuzumab · The use of adjuvant HERCEPTIN IV in the setting of early breast cancer (after surgery and in association with chemotherapy

AusPAR Attachment 1. Product Information for Trastuzumab · The use of adjuvant HERCEPTIN IV in the setting of early breast cancer (after surgery and in association with chemotherapy

Documents
Ado-Trastuzumab Emtansine (Kadcyla®) · PDF filetrastuzumab emtansine combined with pertuzumab vs. ado-trastuzumab emtansine plus pertuzumab placebo vs. trastuzumab plus taxane as

Ado-Trastuzumab Emtansine (Kadcyla®) · PDF filetrastuzumab emtansine combined with pertuzumab vs. ado-trastuzumab emtansine plus pertuzumab placebo vs. trastuzumab plus taxane as

Documents
Article type: Research article · 3/13/2018  · 1 Article type: Research article . p95HER2 methionine 611 carboxy-terminal fragment is predictive of trastuzumab adjuvant treatment

Article type: Research article · 3/13/2018  · 1 Article type: Research article . p95HER2 methionine 611 carboxy-terminal fragment is predictive of trastuzumab adjuvant treatment

Documents
sowie Version 2020.1D Neoadjuvante (Primäre ... - AGO-Online · Trastuzumab (plus Pertuzumab bei N+ oder NST) ++ ... cT>2 Therapie4 Trastuzumab +/- Pertuzumab -DM1 Bei pCR: • Trastuzumab

sowie Version 2020.1D Neoadjuvante (Primäre ... - AGO-Online · Trastuzumab (plus Pertuzumab bei N+ oder NST) ++ ... cT>2 Therapie4 Trastuzumab +/- Pertuzumab -DM1 Bei pCR: • Trastuzumab

Documents
Should clinicians routinely recommend trastuzumab (Herceptin) as part of the adjuvant therapy for all patients with Her2 positive early breast cancer?

Should clinicians routinely recommend trastuzumab (Herceptin) as part of the adjuvant therapy for all patients with Her2 positive early breast cancer?

Documents